Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Known or Suspected Soft Tissue Sarcoma
Phase 2
Terminated
- Conditions
- Sarcoma
- First Posted Date
- 2005-07-26
- Last Posted Date
- 2016-02-25
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 4
- Registration Number
- NCT00123786
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
A Study of Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers
- Conditions
- Breast CancerGliomaProstate CancerCarcinoma, Squamous CellCarcinoma, Non-Small-Cell-LungHead and Neck Cancer
- First Posted Date
- 2005-07-22
- Last Posted Date
- 2016-03-16
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 13
- Registration Number
- NCT00122239
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Exploring Genomic, Proteomic and Dosimetric Determinants of Late Toxicity After Three Dimensional Conformal Radiotherapy (RT) for Prostate Cancer
Terminated
- Conditions
- Prostate Cancer
- First Posted Date
- 2005-07-22
- Last Posted Date
- 2016-02-26
- Lead Sponsor
- AHS Cancer Control Alberta
- Target Recruit Count
- 83
- Registration Number
- NCT00122265
- Locations
- π¨π¦
Cross Cancer Institute, Edmonton, Alberta, Canada
Β© Copyright 2025. All Rights Reserved by MedPath